590 related articles for article (PubMed ID: 8688321)
21. Cytokine modulation of antigen expression in human melanoma cell lines derived from primary and metastatic tumour tissues.
Andalib AR; Lawry J; Ali SA; Murray AK; Sisley K; Silcocks P; Herlyn M; Rees RC
Melanoma Res; 1997 Feb; 7(1):32-42. PubMed ID: 9067963
[TBL] [Abstract][Full Text] [Related]
22. Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma.
Farkas B; Hantschel M; Magyarlaki M; Becker B; Scherer K; Landthaler M; Pfister K; Gehrmann M; Gross C; Mackensen A; Multhoff G
Melanoma Res; 2003 Apr; 13(2):147-52. PubMed ID: 12690297
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
[TBL] [Abstract][Full Text] [Related]
24. In vitro properties of human melanoma cells metastatic in nude mice.
Herlyn D; Iliopoulos D; Jensen PJ; Parmiter A; Baird J; Hotta H; Adachi K; Ross AH; Jambrosic J; Koprowski H
Cancer Res; 1990 Apr; 50(8):2296-302. PubMed ID: 2156614
[TBL] [Abstract][Full Text] [Related]
25. Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients.
Murer K; Urosevic M; Willers J; Selvam P; Laine E; Burg G; Dummer R
Melanoma Res; 2004 Aug; 14(4):257-62. PubMed ID: 15305155
[TBL] [Abstract][Full Text] [Related]
26. Favourable melanoma prognosis associated with the expression of the tumour necrosis factor receptor and the alpha1beta1 integrin: a preliminary report.
Gilhar A; Ullmann Y; Kalish RS; Berkutski T; Azizi E; Bank I
Melanoma Res; 1997 Dec; 7(6):486-95. PubMed ID: 9464621
[TBL] [Abstract][Full Text] [Related]
27. Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12.
Mortarini R; Borri A; Tragni G; Bersani I; Vegetti C; Bajetta E; Pilotti S; Cerundolo V; Anichini A
Cancer Res; 2000 Jul; 60(13):3559-68. PubMed ID: 10910069
[TBL] [Abstract][Full Text] [Related]
28. Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential.
Westphal JR; van't Hullenaar RG; van der Laak JA; Cornelissen IM; Schalkwijk LJ; van Muijen GN; Wesseling P; de Wilde PC; Ruiter DJ; de Waal RM
Br J Cancer; 1997; 76(5):561-70. PubMed ID: 9303353
[TBL] [Abstract][Full Text] [Related]
29. Extrapulmonary, tissue-specific metastasis formation in nude mice injected with FEMX-I human melanoma cells.
Fodstad O; Kjønniksen I; Aamdal S; Nesland JM; Boyd MR; Pihl A
Cancer Res; 1988 Aug; 48(15):4382-8. PubMed ID: 3390834
[TBL] [Abstract][Full Text] [Related]
30. Expression of melanoma-associated antigens in melanoma cell cultures.
Urosevic M; Braun B; Willers J; Burg G; Dummer R
Exp Dermatol; 2005 Jul; 14(7):491-7. PubMed ID: 15946236
[TBL] [Abstract][Full Text] [Related]
31. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
33. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.
Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN
Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM
Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
[TBL] [Abstract][Full Text] [Related]
35. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas.
Marshall JF; Rutherford DC; Happerfield L; Hanby A; McCartney AC; Newton-Bishop J; Hart IR
Br J Cancer; 1998 Feb; 77(4):522-9. PubMed ID: 9484806
[TBL] [Abstract][Full Text] [Related]
37. A metastatic melanoma with an unusual immunophenotypic profile.
Gao Z; Stanek A; Chen S
Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
[TBL] [Abstract][Full Text] [Related]
38. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.
Chi DD; Merchant RE; Rand R; Conrad AJ; Garrison D; Turner R; Morton DL; Hoon DS
Am J Pathol; 1997 Jun; 150(6):2143-52. PubMed ID: 9176405
[TBL] [Abstract][Full Text] [Related]
39. Metastases of human tumors in experimental animals.
Doré JF; Bailly M; Bertrand S
Anticancer Res; 1987; 7(5B):997-1003. PubMed ID: 3324940
[TBL] [Abstract][Full Text] [Related]
40. Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern.
Rofstad EK
Br J Cancer; 1994 Nov; 70(5):804-12. PubMed ID: 7947084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
